Last reviewed · How we verify
NCT05918562
Efficacy of a Low Fiber Diet for Pediatric Colonoscopy Prep
NA trial testing Low fiber diet in Colitis in 80 participants. Status unknown.
1 September 2023
Quick facts
| Lead sponsor | Rhode Island Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 April 2021 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Low fiber diet — full drug profile →
- Standard clear liquid diet
Conditions studied
- Colitis — all drugs for Colitis →
- Gastrointestinal Diseases — all drugs for Gastrointestinal Diseases →
- Pediatric Disorder — all drugs for Pediatric Disorder →
- Pediatric Crohns Disease — all drugs for Pediatric Crohns Disease →
Sponsor
Rhode Island Hospital
Who can join
Adults 10 to 17, any sex, with Colitis or Gastrointestinal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to evaluate if pediatric patients who are undergoing a bowel preparation in anticipation of a colonoscopy may be able to take in a low fiber diet instead of a standard, clear liquid diet, while still accomplishing an adequate bowel prep.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05918562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Low fiber diet
Trials testing the same drug.
- NCT04675606 — Implementing a Low Fiber Diet vs. Regular Diet in Postoperative Colorectal Patients With Ileostomies · NA · unknown
- NCT04159259 — Effect of Pea Fiber Supplementation on the Gut Microbiota and Host Metabolome and Proteome (FIB) · NA · completed
Other recruiting trials for Colitis
Currently open trials in the same condition.
- NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting
- NCT07047339 — Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis · Phase 2, PHASE3 · recruiting
- NCT06206707 — FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis · NA · recruiting
- NCT03819296 — Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer · Phase 1 · recruiting
- NCT04038619 — Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Ca · Phase 1 · recruiting
Other Rhode Island Hospital trials
Trials by the same sponsor.
- NCT06747221 — Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya · NA · not yet recruiting
- NCT07211087 — Improving the Treatment of Depression Among Youth With HIV · NA · not yet recruiting
- NCT06754527 — Options for Navigating Talking About Risk and Adolescent Choices · NA · not yet recruiting
- NCT07144631 — Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome · NA · recruiting
- NCT06942455 — A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05918562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rhode Island Hospital
- Last refreshed: 26 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05918562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing